Brooke Clarke
Public Communications Contact en SYNAIRGEN PLC .
Perfil
Brooke Clarke is currently the Senior Vice President & Head-Communications at Synairgen Plc since 2021.
Prior to this, she worked as the Global Head-Communications & Corporate Affairs at Hikma Pharmaceuticals Plc from 2016 to 2021 and as the Senior Director-Global Corporate Communications at Shire Plc from 2011 to 2016.
Ms. Clarke has a graduate degree from the University of London and an undergraduate degree from the University of Michigan.
Cargos activos de Brooke Clarke
Empresas | Cargo | Inicio |
---|---|---|
SYNAIRGEN PLC | Public Communications Contact | 01/09/2021 |
Antiguos cargos conocidos de Brooke Clarke.
Empresas | Cargo | Fin |
---|---|---|
HIKMA PHARMACEUTICALS PLC | Public Communications Contact | 01/02/2021 |
SHIRE | Public Communications Contact | 01/09/2016 |
Formación de Brooke Clarke.
University of Michigan | Undergraduate Degree |
University of London | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
SYNAIRGEN PLC | Health Technology |
HIKMA PHARMACEUTICALS PLC | Health Technology |
Empresas privadas | 1 |
---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
- Bolsa de valores
- Insiders
- Brooke Clarke